Temsirolimus OverviewTemsirolimus (codenamed CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative and prodrug of sirolimus and is sold as Torisel. Contents 1 Mechanism of action 2 Efficacy 3 Adverse reactions 4 Lung toxicity 5 Dosing 6 See also 7 References...
Read more Temsirolimus Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Temsirolimus
Recent Temsirolimus Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 25mg/ml (25mg/ml)
NDC Database Records for Temsirolimus: (2 results)Sorted by National Drug Code
- 16729-223 Temsirolimus Kit by Accord Healthcare Inc.
- 68083-202 TemsirolimusTemsirolimus Kit by Gland Pharma Limited
Other drugs which contain Temsirolimus or a similar ingredient: (1 result)
Related Temsirolimus Topics: